Top Markets
Coin of the day
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
Rang în acțiuni #27858
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Preț acțiune
$1.00
Ultima sincronizare: 2023-06-01
Capitalizare de piață
$30.11M
Schimbare (1 zi)
2.04%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Angion Biomedica Corp. (ANGN)

Categorie

Istoricul spliturilor pentru Angion Biomedica Corp. (ANGN)
Acțiunea Angion Biomedica Corp. (simbol: ANGN) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 20, 2026.
O acțiune ANGN cumpărată înainte de Aug 20, 2026 este echivalentă astăzi cu 0 acțiuni ANGN.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH